AGCT0521: Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors with Paclitaxel, Ifosfamide and Carboplatin.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Filgrastim; Ifosfamide; Paclitaxel
- Indications Choriocarcinoma; Germ cell and embryonal neoplasms; Yolk sac tumour
- Focus Therapeutic Use
- 29 Aug 2018 Biomarkers information updated
- 03 Aug 2012 Planned end date changed from 1 Jun 2009 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 03 Aug 2012 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.